Opportunities in the Global Fragrances Market for 2025 Featuring L'Oreal, LVMH Moet Hennessy - Louis Vuitton, Coty, Chanel, and Natura &Co
The report provides an overview of current fragrances scenario regarding the future outlook in terms of ingredients, product claims, labeling, distribution, and packaging. The analysis also covers regional overview across five regions - Asia-Pacific, Middle East and Africa, Americas, Western Europe, and Eastern Europe - highlighting industry size, growth drivers, latest developments, and future inhibitors for the regions.
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Opportunities in the Global Fragrances Sector 2025" report has been added to ResearchAndMarkets.com's offering.This report brings together multiple data sources to provide a comprehensive overview of the global fragrances sector, analyzing data from 108 countries.
The global fragrances sector is valued at $59.1 billion in 2024 and is expected to rise to $73.1 billion in 2029, reflecting a compound annual growth rate (CAGR) of 4.4%. Female fragrances constituted the largest category by value, capturing a 53% market share in 2024, followed by male fragrances at 32.2%. Regionally, the Americas led the sector in 2024 with a 45.2% share of the value, followed by Western Europe, which held a 27% share.
Rapid urbanization, rising purchasing power, and the increasing demand for exotic and luxury perfumes are stimulating growth in the global fragrances sector. With the rise in focus on personal grooming, consumers are increasingly incorporating fragrances in their daily routines, fueling sales.
The growing consumer inclination towards incorporating fragrances into their daily grooming routines is pushing the demand for fragrances. Moreover, consumers seek new and innovative secents in fragrances. As a result, manufacturers are formulating novel scent combinations to capitalize on this trend. Consumers are also looking for premium fragrances with high-quality ingredients. Manufacturers are leveraging this trend by introducing luxury fragrances to attract them.Scope
Global snapshot: Includes executive summary, current sector scenarios in terms of ingredients, manufacturer claims, labeling, and packaging. The section also touches on the key growth enablers and inhibitors for the fragrances sector.
Sector snapshot: The analysis provides a global overview, along with regional and category-level data and analysis. It also includes regional overview across five regions-Americas, Asia-Pacific, Eastern Europe, Middle East and Africa (MEA), and Western Europe-highlighting sector size and evolution, value and volume shares by category, and growth drivers for each region.
Consumer trends: Provides an overview of evolving consumer trends, supported by the analyst's in-house consumer surveys, and product examples.
Country deep-dive: Provides risk-reward analysis of the top high-potential countries in each region based on market assessment, economic development, governance indicators, sociodemographic factors, and technological infrastructure. Provides a deep-dive analysis of 10 high-potential countries covering value growth during 2024-29, key challenges, consumer demographics, and key trends. It also includes regional analysis covering the outlook for each region.
Competitive environment and brand shares: Provides an overview of the leading companies and brands at global and regional levels. Market shares of brands and private labels in each region are also detailed.
Distribution overview: Provides an analysis of the leading distribution channels in the global fragrances sector in 2024. It covers modern retail, traditional retail, specialist retail, direct sellers, cash & carries and warehouse clubs, and other distribution channels.
Packaging analysis*: The report provides percentage share (in 2024) and growth analysis (during 2024-29) for various pack materials, pack types, closures, and primary outer types based on volume sales of fragrances.
Select industry metrics: The section provides topline statistics and analysis for different alternate datasets, such as patent filings, job analytics, and deals in the cosmetics and toiletries (C&T) industry in 2024.
Reasons to Buy
Manufacturers and retailers seek latest information on how the market is evolving to formulate their sales and marketing strategies. There is also demand for authentic market data with a high level of detail. This report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities of growth within the sector in the region
The report provides a detailed analysis of the countries in the region, covering the key challenges, competitive landscape and demographic analysis, that can help companies gain insight into the country specific nuances
The analysts have also placed a significant emphasis on the key trends that drive consumer choice and the future opportunities that can be explored in the region, than can help companies in revenue expansion
To gain competitive intelligence about leading brands in the sector in the region with information about their market share and growth rates
Key Topics Covered:
Global Snapshot
Executive Summary
Market Outlook
Enablers and Inhibitors
Sector Snapshot
Global Overview
Regional Overview
Consumer Trends
Country Deep Dive
Identifying High-Potential Countries by Region
Americas
Canada
Chile
Regional Overview
Asia-Pacific
Malaysia
Japan
Regional Overview
Eastern Europe
Poland
Hungary
Regional Overview
MEA
UAE
Saudi Arabia
Regional Overview
Western Europe
Switzerland
Germany
Regional Overview
Competitive Environment
Competitive Landscape - Sector Analysis
Competitive Landscape - Category Analysis
Distribution Overview
Packaging Analysis
Growth Analysis by Key Pack Material and Pack Type
Growth Analysis by Closure Type and Primary Outer Type
Select Industry Metrics
Global Patent Filings
Global Job Analytics
Global Deals
Appendix
Definitions
About the Analyst
A selection of companies mentioned in this report includes, but is not limited to:
L'Oreal
LVMH Moet Hennessy - Louis Vuitton
Coty
Chanel
Natura &Co
For more information about this report visit https://www.researchandmarkets.com/r/ix9akx
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
7 hours ago
- Associated Press
Middle East and North Africa Halal Food Market Analysis Report 2025: Food Safety and Ethical Consumption, & Increasing Demand for Packaged Food Bolster Opportunities - Forecast to 2030
DUBLIN--(BUSINESS WIRE)--Jun 11, 2025-- The 'Halal Food Regional Market Analysis: Middle East and North Africa' report has been added to offering. The Halal Food Regional Market was valued at USD 253.9 billion in 2025, and is projected to reach USD 380 billion by 2030, rising at a CAGR of 7.1%. The report provides an analysis of the Middle East and North Africa (MENA) halal food market. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. It explores various market drivers, such as technological developments, economic influences and strategic business factors. The countries included in the analysis are Saudi Arabia, the United Arab Emirates, Egypt, Iran, the GCC (Gulf Cooperation Council) countries (Qatar, Bahrain, Oman, and Kuwait), and the rest of the MENA region. The MENA region offers a compelling and strategic halal food market research opportunity. With a rapidly expanding Muslim population, the demand for halal products is growing across diverse demographic segments. Rising consumer awareness of halal standards and the increasing influence of ethically conscious buyers are also key drivers of market expansion in the region. Recent improvements in regulatory frameworks across several MENA countries have further enhanced the market landscape. Governments have simplified the halal certification process and created a more supportive environment for industry players. As government and private-sector investments in the halal food industry gain momentum, the MENA region is set to play a pivotal role in the global halal food market. Conducting a market study of the region is crucial for businesses to understand shifting consumer preferences, uncover untapped growth areas and maintain a competitive edge. For companies seeking to scale their presence in the halal sector, the MENA region is too significant to ignore. The report includes: Key Attributes: Key Topics Covered: Chapter 1 Executive Summary Chapter 2 MENA Halal Food Industry Outlook Chapter 3 Market Dynamics Chapter 4 Market Segmentation Analysis Chapter 5 Emerging Markets Chapter 6 Russia-Ukraine War Impact Analysis Chapter 7 Competitive Landscape For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: MIDDLE EAST AFRICA INDUSTRY KEYWORD: FOOD/BEVERAGE RETAIL SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/11/2025 09:39 AM/DISC: 06/11/2025 09:37 AM
Associated Press
9 hours ago
- Associated Press
Biologic Therapeutic Drugs Technology Analysis and Global Market Forecast Report 2024-2025 & 2029 Featuring Key Players - Merck, F. Hoffmann-La Roche, Johnson & Johnson, Pfizer, & Bristol-Myers Squibb
DUBLIN--(BUSINESS WIRE)--Jun 11, 2025-- The 'Biologic Therapeutic Drugs: Technologies and Global Markets' report has been added to offering. The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029. This report provides an overview of the global biologic therapeutic drug market and analyzes market trends. It includes global revenue ($U.S. millions) for base year data for 2023 and estimated data for 2024. The forecast period is 2024 through 2029. The pharmaceutical industry is undergoing tremendous transformations by focusing more on targeted and personalized therapies. The industry is witnessing a shift from traditional synthetic drugs to biologic therapeutic drugs, which are more efficacious, have better patient outcomes and improve quality of life. Biologic drugs are primarily classified into monoclonal antibodies; vaccines; peptide hormones; cell and gene therapies; and others, which include protein therapeutics (e.g., cytokines, enzymes, blood factors, fusion proteins) and other drugs (e.g., RNA-based therapies). The biopharmaceutical industry has recently been witnessing tremendous growth due to the increasing demand for innovative therapies, such as monoclonal antibodies, cell and gene therapies and vaccines. The demand for these therapies is primarily driven by such factors as the increasing prevalence of chronic diseases, rising healthcare expenditures, increasing awareness, novel product launches and strong pipelines. The biologic approvals by the U.S. Food and Drug Administration (FDA) are increasing year on year, and 2023 was marked by the approval of two breakthrough therapies: the gene editing therapy Casgevy from Vertex Pharmaceutical and Leqembi (lecanemab) from Eisai Inc. The entry of biosimilars into the market is expected to erode the revenues of the current branded products upon patent expiry. The complex manufacturing process, a lack of skilled workforce and high development costs translate to a high cost of therapy, which acts as a major barrier to the market. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes corporate environmental, social and governance (ESG) developments and discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the ranking and share of key players in the global biologic therapeutic drug market. It also has a section dedicated to company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players. The report includes: Company Profiles Key Attributes: Key Topics Covered: Chapter 1 Executive Summary Chapter 2 Market Overview Chapter 3 Market Dynamics Chapter 4 Regulatory Landscape Chapter 5 Emerging Technologies and Developments Chapter 6 Market Segmentation Analysis Chapter 7 Competitive Intelligence Chapter 8 Sustainability in Biologics Therapeutic Drug Market: An ESG Perspective Chapter 9 Appendix For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH TECHNOLOGY PHARMACEUTICAL HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/11/2025 08:33 AM/DISC: 06/11/2025 08:32 AM
Associated Press
9 hours ago
- Associated Press
Oncology Diagnostics Global Markets Report 2025: Expanding Cancer Screening and Enhanced Access to Advanced Technologies Bolster Opportunities - Forecast to 2029
DUBLIN--(BUSINESS WIRE)--Jun 11, 2025-- The 'Oncology Diagnostics: Global Markets' report has been added to offering. The global market for oncology diagnostics is estimated to increase from $77.6 billion in 2024 to reach $101.5 billion by 2029, at a compound annual growth rate (CAGR) of 5.5% from 2024 through 2029. The base year for the study is 2023, 2024 is the estimated year, with projections through 2029, including compound annual growth rates (CAGRs) for the forecast period. This report analyzes the oncology diagnostics market and the competitive landscape. The profiles of several leading companies, including their revenues, product portfolios and recent activities are also examined. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. The oncology diagnostics market is growing at a steady rate driven by the increasing incidence and the prevalence of a wide range of cancers globally, R&D and new product launches by the major players in the market, strategic initiatives by the major players, and increasing numbers of private diagnostic centers in emerging markets. Key Attributes: The report includes: Key Topics Covered: Chapter 1 Executive Summary Chapter 2 Market Overview Chapter 3 Market Dynamics Chapter 4 Regulatory Landscape Chapter 5 Emerging Technologies and Developments Chapter 6 Oncology Diagnostics Market Chapter 7 Competitive Intelligence Chapter 8 Sustainability in the Market for Oncology Diagnostics: An ESG Perspective Chapter 9 Appendix List of Tables Summary Table: Global Market for Oncology Diagnostics, by Product Type, Through 2029 Table 1: Global Incidence of All Cancer Cases, by WHO Region, 2022-2045 Table 2: Global Incidence of Cancer Cases, Both Sexes, by Cancer Type, 2022 Table 3: Cancer Treatments Based on Specific Tests Table 4: Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices Table 5: Selected Patent Grants in Oncology Diagnostics, 2023-2025 Table 6: Global Oncology Diagnostics Market, by Product Type, Through 2029 Table 7: Global Diagnostics Imaging Market, by Region, Through 2029 Table 8: Global Endoscopy Market, by Region, Through 2029 Table 9: Global Tumor Biomarker Tests Market, by Region, Through 2029 Table 10: Global Biopsy Devices Market, by Region, Through 2029 Table 11: Global H&E and Special Stains Diagnostics Market, by Region, Through 2029 Table 12: Global IHC Oncology Diagnostics Market, by Region, Through 2029 Table 13: Global ISH Oncology Diagnostics Market, by Region, Through 2029 Table 14: Global PCR Oncology Diagnostics Market, by Region, Through 2029 Table 15: Global NGS Oncology Diagnostics Market, by Region, Through 2029 Table 16: Global Other Oncology Diagnostics Tests Market, by Region, Through 2029 Table 17: Global Oncology Diagnostics Market, by Application, Through 2029 Table 18: Global Breast Cancer Diagnostics Market, by Region, Through 2029 Table 19: Global Lung Cancer Diagnostics Market, by Region, Through 2029 Table 20: Global Colorectal Cancer Diagnostics Market, by Region, Through 2029 Table 21: Global Prostate Cancer Diagnostics Market, by Region, Through 2029 Table 22: Global Gastric Cancer Diagnostics Market, by Region, Through 2029 Table 23: Global Oncology Diagnostics Market in Other Cancer Applications, by Region, Through 2029 Table 24: Global Oncology Diagnostics Market, by End User, Through 2029 Table 25: Global Oncology Diagnostics Market in Hospitals, Cancer Centers and Clinics, Through 2029 Table 26: Global Oncology Diagnostics Market in Diagnostic Imaging and Reference Laboratories, Through 2029 Table 27: Global Oncology Diagnostics Market in Other End Uses, Through 2029 Table 28: Global Oncology Diagnostics Market, by Region, Through 2029 Table 29: North American Oncology Diagnostics Market, by Country, Through 2029 Table 30: U.S. Oncology Diagnostics Market, by Product Type, Through 2029 Table 31: U.S. Oncology Diagnostics Market, by Application, Through 2029 Table 32: U.S. Oncology Diagnostics Market, by End User, Through 2029 Table 33: Canadian Oncology Diagnostics Market, by Product Type, Through 2029 Table 34: Canadian Oncology Diagnostics Market, by Application, Through 2029 Table 35: Canadian Oncology Diagnostics Market, by End User, Through 2029 Table 36: Mexican Oncology Diagnostics Market, by Product Type, Through 2029 Table 37: Mexican Oncology Diagnostics Market, by Application, Through 2029 Table 38: Mexican Oncology Diagnostics Market, by End User, Through 2029 Table 39: European Oncology Diagnostics Market, by Country, Through 2029 Table 40: Cancer Incidence and Mortality Numbers in Germany, Both Sexes, 2022 Table 41: German Oncology Diagnostics Market, by Product Type, Through 2029 Table 42: German Oncology Diagnostics Market, by Application, Through 2029 Table 43: German Oncology Diagnostics Market, by End User, Through 2029 Table 44: Cancer Incidence and Mortality Numbers in France, Both Sexes, 2022 Table 45: French Oncology Diagnostics Market, by Product Type, Through 2029 Table 46: French Oncology Diagnostics Market, by Application, Through 2029 Table 47: French Oncology Diagnostics Market, by End User, Through 2029 Table 48: New Cases of Cancer Diagnosed Each Year in the U.K., 2021 Table 49: The U.K. Oncology Diagnostics Market, by Product Type, Through 2029 Table 50: The U.K. Oncology Diagnostics Market, by Application, Through 2029 Table 51: The U.K. Oncology Diagnostics Market, by End User, Through 2029 Table 52: Cancer Incidence and Mortality Numbers in Italy, Both Sexes, 2022 Table 53: Italian Oncology Diagnostics Market, by Product Type, Through 2029 Table 54: Italian Oncology Diagnostics Market, by Application, Through 2029 Table 55: Italian Oncology Diagnostics Market, by End User, Through 2029 Table 56: Cancer Incidence and Mortality Numbers in Spain, Both Sexes, 2022 Table 57: Spanish Oncology Diagnostics Market, by Product Type, Through 2029 Table 58: Spanish Oncology Diagnostics Market, by Application, Through 2029 Table 59: Spanish Oncology Diagnostics Market, by End User, Through 2029 Table 60: Rest of European Countries' Oncology Diagnostics Market, by Product Type, Through 2029 Table 61: Rest of European Countries' Oncology Diagnostics Market, by Application, Through 2029 Table 62: Rest of European Countries' Oncology Diagnostics Market, by End User, Through 2029 Table 63: Asia-Pacific Oncology Diagnostics Market, by Country, Through 2029 Table 64: Cancer Incidence and Mortality Numbers in China, Both Sexes, 2022 Table 65: Chinese Oncology Diagnostics Market, by Product Type, Through 2029 Table 66: Chinese Oncology Diagnostics Market, by Application, Through 2029 Table 67: Chinese Oncology Diagnostics Market, by End User, Through 2029 Table 68: Cancer Incidence and Mortality Numbers in Japan, Both Sexes, 2022 Table 69: Japanese Oncology Diagnostics Market, by Product Type, Through 2029 Table 70: Japanese Oncology Diagnostics Market, by Application, Through 2029 Table 71: Japanese Oncology Diagnostics Market, by End User, Through 2029 Table 72: Cancer Incidence and Mortality Numbers in India, Both Sexes, 2022 Table 73: Indian Oncology Diagnostics Market, by Product Type, Through 2029 Table 74: Indian Oncology Diagnostics Market, by Application, Through 2029 Table 75: Indian Oncology Diagnostics Market, by End User, Through 2029 Table 76: Rest of Asia-Pacific Oncology Diagnostics Market, by Product Type, Through 2029 Table 77: Rest of Asia-Pacific Oncology Diagnostics Market, by Application, Through 2029 Table 78: Rest of Asia-Pacific Oncology Diagnostics Market, by End User, Through 2029 Table 79: South American Oncology Diagnostics Market, by Country, Through 2029 Table 80: Brazilian Oncology Diagnostics Market, by Product Type, Through 2029 Table 81: Brazilian Oncology Diagnostics Market, by Application, Through 2029 Table 82: Brazilian Oncology Diagnostics Market, by End User, Through 2029 Table 83: Argentine Oncology Diagnostics Market, by Product Type, Through 2029 Table 84: Argentine Oncology Diagnostics Market, by Application, Through 2029 Table 85: Argentine Oncology Diagnostics Market, by End User, Through 2029 Table 86: Rest of South American Oncology Diagnostics Market, by Product Type, Through 2029 Table 87: Rest of South American Oncology Diagnostics Market, by Application, Through 2029 Table 88: Rest of South American Oncology Diagnostics Market, by End User, Through 2029 Table 89: Middle East and African Oncology Diagnostics Market, by Product Type, Through 2029 Table 90: Middle East and African Oncology Diagnostics Market, by Application, Through 2029 Table 91: Middle East and African Oncology Diagnostics Market, by End User, Through 2029 Table 92: Company Shares in the Oncology Diagnostics Market, 2023 Table 93: ESG: Environmental Overview Table 94: ESG: Social Overview Table 95: ESG: Governance Overview Table 96: Abbreviations Used in this Report Table 97: Abbott: Company Snapshot Table 98: Abbott: Financial Performance, FY 2022 and 2023 Table 99: Abbott: Product Portfolio Table 100: Agilent Technologies Inc.: Company Snapshot Table 101: Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024 Table 102: Agilent Technologies Inc.: Product Portfolio Table 103: Agilent Technologies Inc.: News/Key Developments, 2024 Table 104: BD: Company Snapshot Table 105: BD: Financial Performance, FY 2023 and 2024 Table 106: BD: Product Portfolio Table 107: bioMerieux: Company Snapshot Table 108: bioMerieux: Financial Performance, FY 2022 and 2023 Table 109: bioMerieux: Product Portfolio Table 110: Bio-Rad Laboratories Inc.: Company Snapshot Table 111: Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024 Table 112: Bio-Rad Laboratories Inc.: Product Portfolio Table 113: Danaher Corp.: Company Snapshot Table 114: Danaher Corp.: Financial Performance, FY 2022 and 2023 Table 115: Danaher Corp.: Product Portfolio Table 116: Danaher Corp.: News/Key Developments, 2023 Table 117: F. Hoffmann-La Roche Ltd.: Company Snapshot Table 118: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024 Table 119: F. Hoffmann-La Roche Ltd.: Product Portfolio Table 120: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024 and 2025 Table 121: GE HealthCare: Company Snapshot Table 122: GE HealthCare: Financial Performance, FY 2023 and 2024 Table 123: GE HealthCare: Product Portfolio Table 124: GE HealthCare: News/Key Developments, 2024 Table 125: Illumina Inc.: Company Snapshot Table 126: Illumina Inc.: Financial Performance, FY 2023 and 2024 Table 127: Illumina Inc.: Product Portfolio Table 128: Illumina Inc.: News/Key Developments, 2024 Table 129: Koninklijke Philips N.V.: Company Snapshot Table 130: Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024 Table 131: Koninklijke Philips N.V.: Product Portfolio Table 132: Merck KGaA: Company Snapshot Table 133: Merck KGaA: Financial Performance, FY 2022 and 2023 Table 134: Merck KGaA: Product Portfolio Table 135: Myriad Genetics Inc.: Company Snapshot Table 136: Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023 Table 137: Myriad Genetics Inc.: Product Portfolio Table 138: Myriad Genetics Inc.: News/Key Developments, 2025 Table 139: Qiagen: Company Snapshot Table 140: Qiagen: Financial Performance, FY 2022 and 2023 Table 141: Qiagen: Product Portfolio Table 142: Siemens Healthineers AG: Company Snapshot Table 143: Siemens Healthineers AG: Financial Performance, FY 2023 and 2024 Table 144: Siemens Healthineers AG: Product Portfolio Table 145: Siemens Healthineers AG: News/Key Developments, 2024 Table 146: Thermo Fisher Scientific Inc.: Company Snapshot Table 147: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023 Table 148: Thermo Fisher Scientific Inc.: Product Portfolio Table 149: Thermo Fisher Scientific Inc.: News/Key Developments, 2023 Table 150: ZytoVision GmbH: Company Snapshot Table 151: ZytoVision GmbH: Product Portfolio Table 152: Emerging Startups in Oncology Diagnostics Market List of Figures Summary Figure: Global Market Shares of Oncology Diagnostics, by Product Type, 2023 Figure 1: Porter's Five Forces Analysis of the Oncology Market Figure 2: Market Dynamics of Oncology Diagnostics Figure 3: Global Incidence Shares of All Cancer Cases, by Region, 2022 Figure 4: Number of FDA-Approved Companion Diagnostic Devices, 1997-2024 Figure 5: Emerging Trends and Technologies in Oncology Diagnostics Figure 6: Share of Global Market for Oncology Diagnostics, by Product Type, 2023 Figure 7: Share of Global Market for Oncology Diagnostics, by Application, 2023 Figure 8: Shares of Global Market for Oncology Diagnostics, by End User, 2023 Figure 9: Share of Global Market for Oncology Diagnostics, by Region, 2023 Figure 10: Share of North American Market for Oncology Diagnostics, by Country, 2023 Figure 11: Share of European Market for Oncology Diagnostics, by Country, 2023 Figure 12: Breast Cancer Screening Rates in Europe, by Country, 2012 vs. 2022 Figure 13: Cervical Cancer Screening Rates in European Countries, 2022 Figure 14: Colorectal Cancer Screening Rates in European Countries, 2022 Figure 15: Current and Forecasted Cancer Prevalence in the U.K., 2020-2040 Figure 16: Shares of Cancer Cases in Asia and Oceania, Both Sexes, by Cancer Type, 2022 Figure 17: Shares of All Cancer Mortality Cases in Asia and Oceania, Both Sexes, by Cancer Type, 2022 Figure 18: Share of Asia-Pacific Market for Oncology Diagnostics, by Country, 2023 Figure 19: Share of South American Market for Oncology Diagnostics, by Country, 2023 Figure 20: Share of the Global Market for Oncology Diagnostics, by Company, 2023 Figure 21: ESG Pillars Figure 22: Advantages of ESG for Companies Figure 23: Abbott: Revenue Share, by Business Unit, FY 2023 Figure 24: Abbott: Revenue Share, by Country/Region, FY 2023 Figure 25: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024 Figure 26: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024 Figure 27: BD: Revenue Share, by Business Unit, FY 2024 Figure 28: BD: Revenue Share, by Country/Region, FY 2024 Figure 29: bioMerieux: Revenue Share, by Business Unit, FY 2023 Figure 30: bioMerieux: Revenue Share, by Region, FY 2023 Figure 31: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024 Figure 32: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024 Figure 33: Danaher Corp.: Revenue Share, by Business Unit, FY 2023 Figure 34: Danaher Corp.: Revenue Share, by Country/Region, FY 2023 Figure 35: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024 Figure 36: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024 Figure 37: GE HealthCare: Revenue Share, by Business Unit, FY 2024 Figure 38: GE HealthCare: Revenue Share, by Country/Region, FY 2024 Figure 39: Illumina Inc.: Revenue Share, by Business Unit, FY 2024 Figure 40: Illumina Inc.: Revenue Share, by Country/Region, FY 2024 Figure 41: Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2024 Figure 42: Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023 Figure 43: Merck KGaA: Market Share, by Business Unit, 2023 Figure 44: Merck KGaA: Revenue Share, by Country/Region, 2023 Figure 45: Myriad Genetics Inc.: Revenue Share, by Business Unit, 2023 Figure 46: Myriad Genetics Inc.: Revenue Share, by Country/Region, 2023 Figure 47: Qiagen: Revenue Share, by Business Unit, FY 2023 Figure 48: Qiagen: Revenue Share, by Country/Region, FY 2023 Figure 49: Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024 Figure 50: Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024 Figure 51: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023 Figure 52: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023 Companies Featured For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: HEALTH TECHNOLOGY HEALTH ONCOLOGY SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/11/2025 08:39 AM/DISC: 06/11/2025 08:37 AM
